drugset / Trial / NCT05886205

Induced Pluripotent Stem Cell Derived Exosomes Nasal Drops for the Treatment of Refractory Focal Epilepsy

NCT05886205 ↗

NaSingle-groupOpen-labelTreatment

Summary

Evaluate the safety, tolerability, and preliminary efficacy of GD-iEXo-002 nasal drops in the treatment of focal refractory epilepsy

Timeline

Start
2023-06-05
Primary completion
2025-06-13
Completion
2025-11-13

Drugs

EvaluationDrugModalityDoseRoute
Subject iPSC-Exos Unknown 2 ug Intranasal
Subject iPSC-Exos Unknown 6 ug Intranasal
Subject iPSC-Exos Unknown 18 ug Intranasal

Indications